This federal contract award, valued at $7,753.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lacosamide 10 mg/ml solution, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of lacosamide 10 mg/ml solution in 200 ml vials, with a ceiling value of $1,393.08 and an ultimate completion date of December 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,902.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution, a pharmaceutical product, with a completion date of December 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,333.48 firm-fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,720.12 firm-fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution in 200 ml bottles. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This award is for a Delivery Order contract with Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide Lacosamide 50 mg/5 ml cup UD 5 ml to the U.S. Department of Defense's Medical Supply Chain. The award has a ceiling value of $3,000.36 and an ultimate completion date of June 11, 2024. The contract is a Firm Fixed Price arrangement, without any set-aside designations. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,784.54 firm-fixed-price delivery order is for the provision of Lacosamide 10 mg/ml solution, a medication used to treat certain types of seizures. The contract has a period of performance through June 11, 2024 and is not designated as a set-aside. Amerisourcebergen holds a substantial Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200ml quantities, a generic medication used for the treatment of epilepsy and neuropathic pain. The contract has a firm fixed price of $1,370.40 and a completion date of November 14, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of Lacosamide 100 mg/10 ml pharmaceutical products, with an ultimate completion date of April 2, 2024 and a ceiling value of $1,000.12. Amerisourcebergen Drug Corporation, through its Corporate Office...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563830313 - Lacosamide 10 mg/ml solution 200 ml. The contract has a completion date of March 4, 2024 and a potential value of $1,450.26. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery contract (IDC) between...